Effects of intravenous nifekalant as a lifesaving drug for severe ventricular tachyarrhythmias complicating acute coronary syndrome.

Yusu, Satoru; Ikeda, Takanori; Mera, Hisaaki; Miyakoshi, Mutsumi; Miwa, Yosuke; Abe, Atsuko; Tsukada, Takehiro; Ishiguro, Haruhisa; Shimizu, Hisashi; Yoshino, Hideaki

Yusu, Satoru; Ikeda, Takanori; Mera, Hisaaki; Miyakoshi, Mutsumi; Miwa, Yosuke; Abe, Atsuko; Tsukada, Takehiro; Ishiguro, Haruhisa; Shimizu, Hisashi; Yoshino, Hideaki.

Affiliation

Yusu S; The Second Department of Internal Medicine, Kyorin University School of Medicine, Tokyo, Japan.

Circ J ; 73(11): 2021-8, 2009 Nov.

Article in En | MEDLINE | ID: mdl-19724153

Subject(s)

Acute Coronary Syndrome/complications; Acute Coronary Syndrome/drug therapy; Anti-Arrhythmia Agents/administration & dosage; Pyrimidinones/administration & dosage; Tachycardia, Ventricular/drug therapy; Tachycardia, Ventricular/etiology; Ventricular Fibrillation/drug therapy; Ventricular Fibrillation/etiology; Acute Coronary Syndrome/physiopathology; Aged; Amiodarone/administration & dosage; Anti-Arrhythmia Agents/adverse effects; Blood Pressure/drug effects; Electrocardiography/drug effects; Emergency Medical Services; Female; Heart Rate/drug effects; Humans; Infusions, Intravenous; Injections, Intravenous; Lidocaine/administration & dosage; Male; Middle Aged; Pyrimidinones/adverse effects; Tachycardia, Ventricular/physiopathology; Torsades de Pointes/chemically induced; Ventricular Fibrillation/physiopathology

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Pyrimidinones / Ventricular Fibrillation / Tachycardia, Ventricular / Acute Coronary Syndrome / Anti-Arrhythmia Agents Type of study: Guideline Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Circ J Journal subject: ANGIOLOGIA / CARDIOLOGIA Year: 2009 Document type: Article Affiliation country: Japan

Search on Google

Add to My VHL

XML

PubMed Links